Polycystic ovary syndrome physical examination: Difference between revisions
Aditya Ganti (talk | contribs) |
Aditya Ganti (talk | contribs) |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Patients with polycystic ovary syndrome usually appear obese. | Patients with polycystic ovary syndrome usually appear obese. The physical examination findings of PCOS include signs of androgen excess (hirsutism, virilization, or both), insulin resistance (acanthosis nigricans), and the presence of unopposed estrogen action. | ||
==Physical Examination== | ==Physical Examination== | ||
Revision as of 16:23, 14 August 2017
|
Polycystic ovary syndrome Microchapters |
|
Differentiating Polycystic ovary syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Polycystic ovary syndrome physical examination On the Web |
|
American Roentgen Ray Society Images of Polycystic ovary syndrome physical examination |
|
Risk calculators and risk factors for Polycystic ovary syndrome physical examination |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]
Overview
Patients with polycystic ovary syndrome usually appear obese. The physical examination findings of PCOS include signs of androgen excess (hirsutism, virilization, or both), insulin resistance (acanthosis nigricans), and the presence of unopposed estrogen action.
Physical Examination
General appearance
Patients with PCOS appear obese and tired.[1]
Vital Signs
Patients with polycystic ovary syndrome may have elevated blood pressure, with a systolic blood pressure of 130 mm Hg or higher and a diastolic blood pressure of 85 mm Hg or higher.
Skin
- Hyperpigmentation of the skin at the nape of the neck, axillae, area beneath the breasts, and exposed areas.
- Excessive body hair in a male distribution pattern
- Acne
Abdomen
Patients with polycystic ovarian syndrome (PCOS) have abdominal obesity.
References
- ↑ Buggs C, Rosenfield RL (2005). "Polycystic ovary syndrome in adolescence". Endocrinol. Metab. Clin. North Am. 34 (3): 677–705, x. doi:10.1016/j.ecl.2005.04.005. PMC 3477606. PMID 16085166.